JP Morgan Chase
PRCT icon

JP Morgan Chase’s Procept Biorobotics PRCT Stock Holding History

JP Morgan Chase’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-25,000
Closed -$1.44M – 7657
2025
Q2 		$1.44M Hold
25,000
– – ﹤0.01% 4147
2025
Q1 		$1.46M Buy
+25,000
New +$1.71M ﹤0.01% 4090

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase's PRCT Position: Q1 2026 in Review

JP Morgan Chase increased its Procept Biorobotics (PRCT) stake by 475% in Q1 2026, buying an estimated $6.31M and bringing the position to 271,231 shares worth $6.93M. The position accounts for ﹤0.01% of the portfolio, ranked #3013.

JP Morgan Chase first reported a position in PRCT in Q4 2021 and has held it in 18 quarters since. The position peaked at $65.1M in Q3 2024. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • JP Morgan Chase held 271,231 shares of Procept Biorobotics worth $6.93M as of Q1 2026.
  • JP Morgan Chase bought 224,087 Procept Biorobotics shares in Q1 2026, an estimated $6.31M.
  • Procept Biorobotics made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3013 holding.
  • JP Morgan Chase first reported a position in Procept Biorobotics in Q4 2021 and has held it in 18 quarters since.
  • JP Morgan Chase's Procept Biorobotics position peaked at $65.1M in Q3 2024.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.